Written answer
Medicinal Products
1347. Deputy Paul Murphy asked the Minister for Health further to Parliamentary Question No. 1002 of 5 November 2024, given that Melatonin has not been reviewed since 2008, if he will instruct the NCPE to review and include this product for reimbursement under the Community Drugs Schemes; and if he will make a statement on the matter. [46423/24]
Comment on this
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.